SOBRE ESTE EPISÓDIO

Inglês
Estados Unidos da América

TRANSCRIÇÃO 🔗

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de pharmaphorum Podcast.

OUTROS EPISÓDIOS NESTE PODCAST

Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital infrastructure required to deliver prevention at scale isn’t in place. In a new episode of the podcast, pharmaphorum spoke with James Davis, a healthcare expert at PA Consultin…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech compa…
Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.  In a new pharmaphorum podcast, Dr Irina Babina, CEO of oncology R&D platform Concr, discusse…
For a variety of reasons, early stage clinical trials have been moving out of the United States more and more over the past few years, as companies pursue savings and lighter regulatory burden in places like China and Australia. The industry has long urged the US government to take some action to m…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health* When it comes to digital innovation and AI, consideration of using and implementing such responsibly and ethically ever more becomes forefront. But how can pharma lead the way in ethical AI and trust-driv…
Aviso: O podcast e a arte incorporada nesta página são de pharmaphorum, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.